SCHEMBL1207196

SCHEMBL1207196

O=C(O)CCCC=Cc1cccc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.52
NFE2L2 Q16236 5/20 0.50
TOP1 P11387 1/20 0.45
PTGS1 P23219 3/20 0.45
PTGS2 P35354 1/20 0.45
PIN1 Q13526 2/20 0.44
NQO2 P16083 1/20 0.44
FBP1 P09467 1/20 0.43
KMT2A Q03164 3/20 0.42
PPARG P37231 3/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP19A1 P11511 2/20 0.42
PPARD Q03181 2/20 0.42
PPARA Q07869 2/20 0.42
F7 P08709 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
F3 P13726 1/20 0.42
RXRA P19793 1/20 0.42
OXER1 Q8TDS5 1/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1207193 1.00 TBXAS1 (0.52) TBXAS1NFE2L2TOP1PTGS1PTGS2
SCHEMBL1005586 0.94 TBXAS1 (0.57) TBXAS1NFE2L2PTGS1PTGS2KMT2A
SCHEMBL1005587 0.94 TBXAS1 (0.57) TBXAS1NFE2L2PTGS1PTGS2KMT2A
SCHEMBL29263708 0.83 CYP4F2 (0.46) NFE2L2PTGS1PTGS2KMT2AMEN1
SCHEMBL31035917 0.83 CYP4F2 (0.46) NFE2L2PTGS1PTGS2KMT2AMEN1
SCHEMBL2379927 0.82 TBXAS1 (0.62) TBXAS1TOP1PTGS1KMT2APPARG
SCHEMBL1363095 0.82 TBXAS1 (0.62) TBXAS1TOP1PTGS1KMT2APPARG
SCHEMBL8798110 0.82 TBXAS1 (0.62) TBXAS1TOP1PTGS1KMT2APPARG
SCHEMBL1206860 0.82 PTGS2 (0.54) NFE2L2PTGS1PTGS2KMT2AALDH1A1
SCHEMBL18126612 0.82 CYP1A2 (0.53) TBXAS1TOP1FBP1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) 2022-02-22 US disclosed
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS NOVO NORDISK A/S (DK) 2020-12-31 US disclosed
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents EMISPHERE TECHNOLOGIES, INC. (US) 2019-10-29 US disclosed
EP-2114145-B1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECH INC (US) 2017-11-01 EP disclosed
US-20160375135-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2016-12-29 US disclosed
US-20120258911-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2012-10-11 US disclosed
US-20110046050-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2011-02-24 US disclosed
EP-2114145-A2 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS Emisphere Technologies, Inc. (US) 2009-11-11 EP disclosed
WO-2008112368-A2 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA TBXAS1 1502/4885NFE2L2 1099/4885TOP1 1589/4885
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA TBXAS1 1502/4885NFE2L2 1099/4885TOP1 1589/4885
US-20110046050-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA TBXAS1 1502/4885NFE2L2 1099/4885TOP1 1589/4885
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA TBXAS1 1502/4885NFE2L2 1099/4885TOP1 1589/4885
US-20160375135-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA TBXAS1 1502/4885NFE2L2 1099/4885TOP1 1589/4885
US-20120258911-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA TBXAS1 1502/4885NFE2L2 1099/4885TOP1 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.